thanks Istari
I've tried reading up more on NRT but since the "don't know what to call it" thing that happened to the phase III trial of phenathingumy, I am unintelligently put off by it.
It's like they had this vary promising drug (that could complete with PRR) and the patient hiring just stopped short during phase III because money dried up, but they have other drugs in the pipeline.
What surprises me is the lack of discussion around this on the NRT thread.
Is Novogen a potential winner or not ?
I know you haven't made your mind up yet, so I am not expecting that you can answer.
cheers
thank the lord we will now be saved, page-9
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.8¢ | 31.0¢ | $897.5K | 2.872M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 79201 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 138883 | 3 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |